table of content
1 Study Coverage
1.1 Biologic Therapeutics Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Biologic Therapeutics Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Avian Cell Culture
1.2.3 Yeast
1.2.4 Bacteria
1.2.5 Insects Cell Culture
1.2.6 Transgenics
1.3 Market by Application
1.3.1 Global Biologic Therapeutics Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Rheumatoid Arthritis
1.3.3 Anemia
1.3.4 Cancer
1.3.5 Diabetes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biologic Therapeutics Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Biologic Therapeutics Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Biologic Therapeutics Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Biologic Therapeutics Drugs Sales by Region
2.4.1 Global Biologic Therapeutics Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Biologic Therapeutics Drugs by Region (2023-2028)
2.5 Global Biologic Therapeutics Drugs Revenue by Region
2.5.1 Global Biologic Therapeutics Drugs Revenue by Region (2017-2022)
2.5.2 Global Biologic Therapeutics Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Biologic Therapeutics Drugs Sales by Manufacturers
3.1.1 Global Top Biologic Therapeutics Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Biologic Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biologic Therapeutics Drugs in 2021
3.2 Global Biologic Therapeutics Drugs Revenue by Manufacturers
3.2.1 Global Biologic Therapeutics Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Biologic Therapeutics Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Biologic Therapeutics Drugs Revenue in 2021
3.3 Global Biologic Therapeutics Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Biologic Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Biologic Therapeutics Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biologic Therapeutics Drugs Sales by Type
4.1.1 Global Biologic Therapeutics Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Biologic Therapeutics Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Biologic Therapeutics Drugs Sales Market Share by Type (2017-2028)
4.2 Global Biologic Therapeutics Drugs Revenue by Type
4.2.1 Global Biologic Therapeutics Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Biologic Therapeutics Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Biologic Therapeutics Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Biologic Therapeutics Drugs Price by Type
4.3.1 Global Biologic Therapeutics Drugs Price by Type (2017-2022)
4.3.2 Global Biologic Therapeutics Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Biologic Therapeutics Drugs Sales by Application
5.1.1 Global Biologic Therapeutics Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Biologic Therapeutics Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Biologic Therapeutics Drugs Sales Market Share by Application (2017-2028)
5.2 Global Biologic Therapeutics Drugs Revenue by Application
5.2.1 Global Biologic Therapeutics Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Biologic Therapeutics Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Biologic Therapeutics Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Biologic Therapeutics Drugs Price by Application
5.3.1 Global Biologic Therapeutics Drugs Price by Application (2017-2022)
5.3.2 Global Biologic Therapeutics Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Biologic Therapeutics Drugs Market Size by Type
6.1.1 North America Biologic Therapeutics Drugs Sales by Type (2017-2028)
6.1.2 North America Biologic Therapeutics Drugs Revenue by Type (2017-2028)
6.2 North America Biologic Therapeutics Drugs Market Size by Application
6.2.1 North America Biologic Therapeutics Drugs Sales by Application (2017-2028)
6.2.2 North America Biologic Therapeutics Drugs Revenue by Application (2017-2028)
6.3 North America Biologic Therapeutics Drugs Market Size by Country
6.3.1 North America Biologic Therapeutics Drugs Sales by Country (2017-2028)
6.3.2 North America Biologic Therapeutics Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Biologic Therapeutics Drugs Market Size by Type
7.1.1 Europe Biologic Therapeutics Drugs Sales by Type (2017-2028)
7.1.2 Europe Biologic Therapeutics Drugs Revenue by Type (2017-2028)
7.2 Europe Biologic Therapeutics Drugs Market Size by Application
7.2.1 Europe Biologic Therapeutics Drugs Sales by Application (2017-2028)
7.2.2 Europe Biologic Therapeutics Drugs Revenue by Application (2017-2028)
7.3 Europe Biologic Therapeutics Drugs Market Size by Country
7.3.1 Europe Biologic Therapeutics Drugs Sales by Country (2017-2028)
7.3.2 Europe Biologic Therapeutics Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Biologic Therapeutics Drugs Market Size by Type
8.1.1 Asia Pacific Biologic Therapeutics Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Biologic Therapeutics Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Biologic Therapeutics Drugs Market Size by Application
8.2.1 Asia Pacific Biologic Therapeutics Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Biologic Therapeutics Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Biologic Therapeutics Drugs Market Size by Region
8.3.1 Asia Pacific Biologic Therapeutics Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Biologic Therapeutics Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Biologic Therapeutics Drugs Market Size by Type
9.1.1 Latin America Biologic Therapeutics Drugs Sales by Type (2017-2028)
9.1.2 Latin America Biologic Therapeutics Drugs Revenue by Type (2017-2028)
9.2 Latin America Biologic Therapeutics Drugs Market Size by Application
9.2.1 Latin America Biologic Therapeutics Drugs Sales by Application (2017-2028)
9.2.2 Latin America Biologic Therapeutics Drugs Revenue by Application (2017-2028)
9.3 Latin America Biologic Therapeutics Drugs Market Size by Country
9.3.1 Latin America Biologic Therapeutics Drugs Sales by Country (2017-2028)
9.3.2 Latin America Biologic Therapeutics Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Biologic Therapeutics Drugs Market Size by Type
10.1.1 Middle East and Africa Biologic Therapeutics Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Biologic Therapeutics Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Biologic Therapeutics Drugs Market Size by Application
10.2.1 Middle East and Africa Biologic Therapeutics Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Biologic Therapeutics Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Biologic Therapeutics Drugs Market Size by Country
10.3.1 Middle East and Africa Biologic Therapeutics Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Biologic Therapeutics Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Biologic Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Biologic Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Biologic Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Overview
11.4.3 Merck Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merck Biologic Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Recent Developments
11.5 Smith Medical
11.5.1 Smith Medical Corporation Information
11.5.2 Smith Medical Overview
11.5.3 Smith Medical Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Smith Medical Biologic Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Smith Medical Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Overview
11.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GlaxoSmithKline Biologic Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GlaxoSmithKline Recent Developments
11.7 Concord Biotech
11.7.1 Concord Biotech Corporation Information
11.7.2 Concord Biotech Overview
11.7.3 Concord Biotech Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Concord Biotech Biologic Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Concord Biotech Recent Developments
11.8 Aurobindo Pharma
11.8.1 Aurobindo Pharma Corporation Information
11.8.2 Aurobindo Pharma Overview
11.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Aurobindo Pharma Biologic Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Aurobindo Pharma Recent Developments
11.9 H. Lundbeck
11.9.1 H. Lundbeck Corporation Information
11.9.2 H. Lundbeck Overview
11.9.3 H. Lundbeck Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 H. Lundbeck Biologic Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 H. Lundbeck Recent Developments
11.10 Retractable Technologies
11.10.1 Retractable Technologies Corporation Information
11.10.2 Retractable Technologies Overview
11.10.3 Retractable Technologies Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Retractable Technologies Biologic Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Retractable Technologies Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biologic Therapeutics Drugs Industry Chain Analysis
12.2 Biologic Therapeutics Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biologic Therapeutics Drugs Production Mode & Process
12.4 Biologic Therapeutics Drugs Sales and Marketing
12.4.1 Biologic Therapeutics Drugs Sales Channels
12.4.2 Biologic Therapeutics Drugs Distributors
12.5 Biologic Therapeutics Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Biologic Therapeutics Drugs Industry Trends
13.2 Biologic Therapeutics Drugs Market Drivers
13.3 Biologic Therapeutics Drugs Market Challenges
13.4 Biologic Therapeutics Drugs Market Restraints
14 Key Findings in The Global Biologic Therapeutics Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer